MinaPharm Pharmaceuticals   Report issue

For profit Phase 1 Phase 4
Founded: Cairo Egypt (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2012
NCT01649245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

MinaPharm Pharmaceuticals

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hematoma (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12